Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma

We previously showed that the proteasome inhibitor carfilzomib and the histone deacetylase inhibitor (HDACI) vorinostat cooperated to induce cell apoptosis in one T-cell leukemia cell line in vitro, implying the possibility of the combination treatment of carfilzomib and vorinostat as a potential th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Minjie, Chen, Gege, Wang, Houcai, Xie, Bingqian, Hu, Liangning, Kong, Yuanyuan, Yang, Guang, Tao, Yi, Han, Ying, Wu, Xiaosong, Zhang, Yiwen, Dai, Bojie, Shi, Jumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045381/
https://www.ncbi.nlm.nih.gov/pubmed/27074555
http://dx.doi.org/10.18632/oncotarget.8667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045381/
https://www.ncbi.nlm.nih.gov/pubmed/27074555
http://dx.doi.org/10.18632/oncotarget.8667

Ejemplares similares